Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

著者: William D. Tap, Zsuzsanna Pápai, Brian A. Van Tine, Steven Attia, Kristen N. Ganjoo, Robin L. Jones, Scott M. Schuetze, Damon R. Reed, Sant P. Chawla, Richard F. Riedel, Anders Krarup‐Hansen, Maud Toulmonde, Isabelle Ray‐Coquard, Peter Hohenberger, Giovanni Grignani, Lee D. Cranmer, Scott H. Okuno, Mark Agulnik, William L. Read, Christopher W. Ryan, Thierry Alcindor, Xavier F Garcia del Muro, G. Thomas Budd, Hussein A. Tawbi, Tillman Pearce, Stew Kroll, Denise K. Reinke, Patrick Schöffski - The Lancet 2017 被引用: 306